Skip to main content
Top
Published in: Radiation Oncology 1/2015

Open Access 01-12-2015 | Research

Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy

Authors: Jianbo Yang, Chao Ding, Tenghui Zhang, Liang Zhang, Tengfei Lv, Xiaolong Ge, Jianfeng Gong, Weiming Zhu, Ning Li, Jieshou Li

Published in: Radiation Oncology | Issue 1/2015

Login to get access

Abstract

Background

Radical hysterectomy and radiotherapy have long been mainstays of cervical cancer treatment. Early stage cervical cancer (FIGO stage IB1–IIA) is traditionally treated using radical surgery combined with radiotherapy, while locally advanced cervical cancer is treated using radiotherapy alone or chemoradiotherapy. In this retrospective study, we describe and analyse the presenting clinical features and outcomes in our cohort and evaluate possible risk factors for postoperative morbidity in women who underwent surgery for chronic radiation enteropathy (CRE).

Methods

One hundred sixty-six eligible cervical cancer patients who underwent surgery for CRE were retrospectively identified between September 2003 and July 2014 in a prospectively maintained database. Among them, 46 patients received radical radiotherapy (RRT) and 120 received radical surgery plus radiotherapy (RS + RT). Clinical features, postoperative morbidity and mortality, and risk factors for postoperative morbidity were analysed.

Results

RS + RT group patients were more likely to present with RTOG/EORTC grade III late morbidity (76.1 % vs 92.5 %; p = 0.004), while RRT group patients tended to show RTOG/EORTC grade IV late morbidity (23.9 % vs 7.5 %; p = 0.004). One hundred forty patients (84.3 %) were treated with aggressive resection (anastomosis 57.8 % and stoma 26.5 %). Overall and major morbidity, mortality and incidence of reoperation in the RRT and RS + RT groups did not differ significantly (63 % vs 64.2 % [p = 1.000], 21.7 % vs 11.7 % [p = 0.137], 6.5 % vs 0.8 % [p = 0.065] and 6.5 % vs 3.3 % [p = 0.360], respectively). However, incidence of permanent stoma and mortality during follow-up was higher in the RRT group than in the RS + RT group (44.2 % vs 12.6 % [p = 0.000] and 16.3 % vs 3.4 % [p = 0.004], respectively). In multivariate analysis, preoperative anaemia was significantly associated with overall morbidity (p = 0.015), while severe intra-abdominal adhesion (p = 0.017), ASA grades III–V (P = 0.022), and RTOG grade IV morbidity (P = 0.018) were predicators of major morbidity.

Conclusions

Radiation-induced late morbidity tended to be severe in the RRT group with more patients suffering RTOG/EORTC grade IV morbidity, while there were no significant differences in postoperative morbidity, mortality and reoperation. Aggressive resection was feasible with acceptable postoperative outcomes. Severe intra-abdominal adhesion, ASA grades III–V and RTOG/EORTC grade IV late morbidity contributed significantly to major postoperative morbidity.
Literature
1.
go back to reference Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014. doi:10.1002/ijc.29210. Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014. doi:10.​1002/​ijc.​29210.
5.
7.
go back to reference Leborgne F, Leborgne JH, Doldan R, Zubizarreta E, Ortega B, Maisonneuve J, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys. 1997;37(2):343–50.PubMedCrossRef Leborgne F, Leborgne JH, Doldan R, Zubizarreta E, Ortega B, Maisonneuve J, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys. 1997;37(2):343–50.PubMedCrossRef
10.
go back to reference Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol. 2014. doi:10.1016/j.ygyno.2014.08.027.PubMed Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol. 2014. doi:10.​1016/​j.​ygyno.​2014.​08.​027.PubMed
11.
go back to reference Chopra S, Dora T, Chinnachamy AN, Thomas B, Kannan S, Engineer R, et al. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study. Int J Radiat Oncol Biol Phys. 2014;88(3):630–5. doi:10.1016/j.ijrobp.2013.11.214.PubMedCrossRef Chopra S, Dora T, Chinnachamy AN, Thomas B, Kannan S, Engineer R, et al. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study. Int J Radiat Oncol Biol Phys. 2014;88(3):630–5. doi:10.​1016/​j.​ijrobp.​2013.​11.​214.PubMedCrossRef
13.
24.
go back to reference Syed AM, Puthawala AA, Abdelaziz NN, ElNaggar M, Disaia P, Berman M. Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54(1):67–78.PubMedCrossRef Syed AM, Puthawala AA, Abdelaziz NN, ElNaggar M, Disaia P, Berman M. Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54(1):67–78.PubMedCrossRef
26.
go back to reference Biewenga P, Mutsaerts MA, Stalpers LJ, Buist MR, Schilthuis MS, van der Velden J. Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer? Int J Gynecol Cancer. 2010;20(3):471–5. doi:10.1111/IGC.0b013e3181d224c8.PubMedCrossRef Biewenga P, Mutsaerts MA, Stalpers LJ, Buist MR, Schilthuis MS, van der Velden J. Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer? Int J Gynecol Cancer. 2010;20(3):471–5. doi:10.​1111/​IGC.​0b013e3181d224c8​.PubMedCrossRef
27.
go back to reference Pourquier H, Dubois JB, Delard R. Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys. 1982;8(11):1887–95.PubMedCrossRef Pourquier H, Dubois JB, Delard R. Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys. 1982;8(11):1887–95.PubMedCrossRef
28.
go back to reference Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999;44(4):855–66.PubMedCrossRef Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999;44(4):855–66.PubMedCrossRef
29.
go back to reference Kasibhatla M, Clough RW, Montana GS, Oleson JR, Light K, Steffey BA, et al. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2006;65(2):398–403. doi:10.1016/j.ijrobp.2005.12.008.PubMedCrossRef Kasibhatla M, Clough RW, Montana GS, Oleson JR, Light K, Steffey BA, et al. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2006;65(2):398–403. doi:10.​1016/​j.​ijrobp.​2005.​12.​008.PubMedCrossRef
33.
go back to reference Regimbeau JM, Panis Y, Gouzi JL, Fagniez PL. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg. 2001;182(3):237–42.PubMedCrossRef Regimbeau JM, Panis Y, Gouzi JL, Fagniez PL. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg. 2001;182(3):237–42.PubMedCrossRef
35.
go back to reference McBride WH, Mason KA, Davis C, Withers HR, Smathers JB. Adhesion formation in experimental chronic radiation enteropathy. Int J Radiat Oncol Biol Phys. 1989;16(3):737–43.PubMedCrossRef McBride WH, Mason KA, Davis C, Withers HR, Smathers JB. Adhesion formation in experimental chronic radiation enteropathy. Int J Radiat Oncol Biol Phys. 1989;16(3):737–43.PubMedCrossRef
Metadata
Title
Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy
Authors
Jianbo Yang
Chao Ding
Tenghui Zhang
Liang Zhang
Tengfei Lv
Xiaolong Ge
Jianfeng Gong
Weiming Zhu
Ning Li
Jieshou Li
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2015
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-015-0433-5

Other articles of this Issue 1/2015

Radiation Oncology 1/2015 Go to the issue